In-Silico Structure Database (LMISSD)
BackLMISSD: Lipid Classification search results
Fatty Acyls [FA](W) --> Docosanoids [FA04] --> Neuroprostanes [FA0401]
LM_ID | Common Name | Systematic Name | Formula | Mass |
---|---|---|---|---|
LMFA04010053 | ent-10,13-diepi-4-Ft-NeuroP | (S,4Z,7Z,11E)-12-((1S,2S,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
LMFA04010054 | ent-10-epi-4-Fc-NeuroP | (S,4Z,7Z,11E)-12-((1S,2R,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
LMFA04010055 | 10-F4c-NeuroP | (S,4Z,7Z,11E)-12-((1R,2S,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
LMFA04010056 | 13-epi-10-F4t-NeuroP | (S,4Z,7Z,11E)-12-((1R,2R,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
LMFA04010057 | 13-epi-10-F4c-NeuroP | (S,4Z,7Z,11E)-12-((1S,2S,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
LMFA04010058 | 10-F4t-NeuroP | (S,4Z,7Z,11E)-12-((1S,2R,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
LMFA04010059 | ent-11-F4t-NeuroP | 3-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010060 | ent-4-epi-11-F4c-NeuroP | 3-((1R,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010061 | ent-4-epi-11-F4t-NeuroP | 3-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010062 | ent-11-F4c-NeuroP | 3-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010063 | 11-epi-11-F4c-NeuroP | 3-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010064 | 4,11-diepi-11-F4t-NeuroP | 3-((1R,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010065 | 4,11-diepi-11-F4c-NeuroP | 3-((1S,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010066 | 11-epi-11-F4t-NeuroP | 3-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010067 | ent-11-epi-4-Ft-NeuroP | 3-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010068 | ent-4,11-diepi-4-Fc-NeuroP | 3-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010069 | ent-4,11-diepi-4-Ft-NeuroP | 3-((1S,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010070 | ent-11-epi-4-Fc-NeuroP | 3-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010071 | 11-F4c-NeuroP | 3-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010072 | 4-epi-11-F4t-NeuroP | 3-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010073 | 4-epi-11-F4c-NeuroP | 3-((1S,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010074 | 11-F4t-NeuroP | 3-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
LMFA04010075 | ent-13-F4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010076 | ent-16-epi-13-F4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010077 | ent-16-epi-13-F4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010078 | ent-13-F4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010079 | 13-epi-13-F4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2S,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010080 | 13,16-diepi-13-F4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010081 | 13,16-diepi-13-F4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2S,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010082 | 13-epi-13-F4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010083 | ent-13-epi-13-F4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010084 | ent-13,16-diepi-13-F4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010085 | ent-13,16-diepi-13-F4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010086 | ent-13-epi-13-F4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010087 | 13-F4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2S,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010088 | 16-epi-13-F4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010089 | 16-epi-13-F4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2S,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010090 | 13-F4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
LMFA04010091 | ent-14-F4t-NeuroP | (Z)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |
LMFA04010092 | ent-7-epi-14-F4c-NeuroP | (Z)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |
LMFA04010093 | ent-7-epi-14-F4t-NeuroP | (Z)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |
LMFA04010094 | ent-14-F4c-NeuroP | (Z)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |
LMFA04010095 | ent-14-epi-14-F4t-NeuroP | (Z)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |
LMFA04010096 | ent-7,14-diepi-14-F4c-NeuroP | (Z)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |
LMFA04010097 | ent-7,14-diepi-14-F4t-NeuroP | (Z)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |
LMFA04010098 | ent-14-epi-14-F4t-NeuroP | (Z)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |
LMFA04010099 | 14-epi-14-F4c-NeuroP | (Z)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |
LMFA04010100 | 7,14-diepi-14-F4t-NeuroP | (Z)-6-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |
LMFA04010101 | 7,14-diepi-14-F4c-NeuroP | (Z)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |
LMFA04010102 | 14-epi-14-F4t-NeuroP | (Z)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |